摘要
胰腺癌是预后最差的癌症之一,其高转移率和化疗药物耐药性一直是困扰医学界的难题。目前关于百里醌对胰腺癌影响的研究受到了人们的广泛关注,其可以通过抑制癌细胞增殖、促进癌细胞凋亡、抑制侵袭与转移、增强化疗药物敏感性、抗炎等方面发挥对胰腺癌的抗癌作用。该综述简要介绍了国内外对两者关系的研究现状,为下一步的研究提供参考。
Pancreatic cancer is one of the cancers with the worst prognosis,and its high metastasis rate and resistance to chemotherapy drugs have always been the tough problems in the medical field.At present,the effect of thymoquinone on pancreatic cancer has attracted wide attention,and it can exert an antitumor effect in pancreatic cancer by inhibiting cancer cell proliferation,promoting cancer cell apoptosis,inhibiting invasion and metastasis,enhancing the sensitivity to chemotherapy drugs,and exerting an anti-inflammatory effect.This review briefly introduces the current research status of the association between thymoquinone and pancreatic cancer in China and globally,so as to provide a reference for subsequent research.
作者
赵占学
刘林勋
李帅
侯晓凡
杨金煜
ZHAO Zhanxue;LIU Linxun;LI Shuai;HOU Xiaofan;YANG Jinyu(Medical College of Soochow University,Suzhou,Jiangsu 215123,China;Department of General Surgery,Qinghai Provincial People’s Hospital,Xining 810007,China;Department of Clinical Pharmacy,The Affiliated Hospital of Qinghai University,Xining 810001,China;Graduate School of Qinghai University,Xining 810016,China)
出处
《临床肝胆病杂志》
CAS
北大核心
2023年第5期1234-1244,共11页
Journal of Clinical Hepatology
基金
青海省卫生健康委员会指导性计划课题(2021-wjzdx-18)。
关键词
胰腺肿瘤
百里醌
治疗学
Pancreatic Neoplasms
Thymoquinone
Therapeutics